NDC 25682-022 – Ultomiris
Ravulizumab 300 mg/30mL · Solution, Concentrate · Intravenous
Product NDC25682-022
Product details
- Brand name
- Ultomiris
- Generic name
- Ravulizumab
- Labeler
- Alexion Pharmaceuticals Inc.
- Dosage form
- Solution, Concentrate
- Route
- Intravenous
- Marketing category
- BLA · BLA761108
- Marketed since
- December 21, 2018
- Listing expires
- December 31, 2026
- Pharmacologic class
- Complement Inhibitor
Active ingredients
- Ravulizumab 300 mg/30mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 25682-022-01 | 1 VIAL, GLASS in 1 CARTON (25682-022-01) / 30 mL in 1 VIAL, GLASS | Dec 21, 2018 |